FR2822069B1 - Composition pharmaceutique comprenant un compose stimulant la secretion d'insuline et un derive de thiazolidinedione et son utilisation pour la preparation de medicamments destines a traiter le diabete - Google Patents

Composition pharmaceutique comprenant un compose stimulant la secretion d'insuline et un derive de thiazolidinedione et son utilisation pour la preparation de medicamments destines a traiter le diabete

Info

Publication number
FR2822069B1
FR2822069B1 FR0103704A FR0103704A FR2822069B1 FR 2822069 B1 FR2822069 B1 FR 2822069B1 FR 0103704 A FR0103704 A FR 0103704A FR 0103704 A FR0103704 A FR 0103704A FR 2822069 B1 FR2822069 B1 FR 2822069B1
Authority
FR
France
Prior art keywords
medicaments
preparation
pharmaceutical composition
insulin secretion
treating diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0103704A
Other languages
English (en)
Other versions
FR2822069A1 (fr
Inventor
Gerard Moinet
Gerard Botton
Didier Mesangeau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
LIPHA SAS
LIPHA Liyonnaise Industrielle Pharmaceutique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0103704A priority Critical patent/FR2822069B1/fr
Application filed by LIPHA SAS, LIPHA Liyonnaise Industrielle Pharmaceutique filed Critical LIPHA SAS
Priority to BR0208122-9A priority patent/BR0208122A/pt
Priority to CA002442000A priority patent/CA2442000A1/fr
Priority to EP02716828A priority patent/EP1370269A2/fr
Priority to PL02362702A priority patent/PL362702A1/xx
Priority to US10/472,081 priority patent/US20040097567A1/en
Priority to PCT/EP2002/002561 priority patent/WO2002074228A2/fr
Priority to KR10-2003-7011072A priority patent/KR20040025898A/ko
Priority to ARP020100963A priority patent/AR033434A1/es
Publication of FR2822069A1 publication Critical patent/FR2822069A1/fr
Application granted granted Critical
Publication of FR2822069B1 publication Critical patent/FR2822069B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
FR0103704A 2001-03-19 2001-03-19 Composition pharmaceutique comprenant un compose stimulant la secretion d'insuline et un derive de thiazolidinedione et son utilisation pour la preparation de medicamments destines a traiter le diabete Expired - Fee Related FR2822069B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0103704A FR2822069B1 (fr) 2001-03-19 2001-03-19 Composition pharmaceutique comprenant un compose stimulant la secretion d'insuline et un derive de thiazolidinedione et son utilisation pour la preparation de medicamments destines a traiter le diabete
CA002442000A CA2442000A1 (fr) 2001-03-19 2002-03-08 Composition pharmaceutique
EP02716828A EP1370269A2 (fr) 2001-03-19 2002-03-08 Composition pharmaceutique pour le traitement du diabete comprenant un derive 5-phenoxyalkyl-2,4-thiazolidinedione et un compose stimulant la secretion de l'insuline
PL02362702A PL362702A1 (en) 2001-03-19 2002-03-08 Pharmaceutical composition for the treatment of diabetes comprising a 5-phenoxyalkal-2,4-thiazolidinedione derivative and a compound that stimulates insulin secretion
BR0208122-9A BR0208122A (pt) 2001-03-19 2002-03-08 Composição farmacêutica
US10/472,081 US20040097567A1 (en) 2001-03-19 2002-03-08 Pharmaceutical composition
PCT/EP2002/002561 WO2002074228A2 (fr) 2001-03-19 2002-03-08 Composition pharmaceutique
KR10-2003-7011072A KR20040025898A (ko) 2001-03-19 2002-03-08 약제학적 조성물
ARP020100963A AR033434A1 (es) 2001-03-19 2002-03-19 Composicion farmaceutica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0103704A FR2822069B1 (fr) 2001-03-19 2001-03-19 Composition pharmaceutique comprenant un compose stimulant la secretion d'insuline et un derive de thiazolidinedione et son utilisation pour la preparation de medicamments destines a traiter le diabete

Publications (2)

Publication Number Publication Date
FR2822069A1 FR2822069A1 (fr) 2002-09-20
FR2822069B1 true FR2822069B1 (fr) 2003-06-20

Family

ID=8861295

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0103704A Expired - Fee Related FR2822069B1 (fr) 2001-03-19 2001-03-19 Composition pharmaceutique comprenant un compose stimulant la secretion d'insuline et un derive de thiazolidinedione et son utilisation pour la preparation de medicamments destines a traiter le diabete

Country Status (9)

Country Link
US (1) US20040097567A1 (fr)
EP (1) EP1370269A2 (fr)
KR (1) KR20040025898A (fr)
AR (1) AR033434A1 (fr)
BR (1) BR0208122A (fr)
CA (1) CA2442000A1 (fr)
FR (1) FR2822069B1 (fr)
PL (1) PL362702A1 (fr)
WO (1) WO2002074228A2 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2749583B1 (fr) * 1996-06-07 1998-08-21 Lipha Nouveaux derives de thiazolidine -2,4- dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
DE69939485D1 (de) * 1998-11-12 2008-10-16 Smithkline Beecham Plc Arzneimittel zur gesteuerten freisetzung eines insulin sensibilisators und metformin

Also Published As

Publication number Publication date
AR033434A1 (es) 2003-12-17
CA2442000A1 (fr) 2002-09-26
US20040097567A1 (en) 2004-05-20
PL362702A1 (en) 2004-11-02
FR2822069A1 (fr) 2002-09-20
WO2002074228A2 (fr) 2002-09-26
BR0208122A (pt) 2004-03-02
KR20040025898A (ko) 2004-03-26
EP1370269A2 (fr) 2003-12-17
WO2002074228A3 (fr) 2003-02-20

Similar Documents

Publication Publication Date Title
FR2774591B1 (fr) Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie
HK1045111A1 (en) (3-Trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin reisistance and type 2 diabetes
CY1110287T1 (el) Χρηση της ανθρωπινης παραθυρεοειδους ορμονης
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
EP1421933A4 (fr) Utilisation de composes de stilbene dans la preparation de medicaments pour le traitement ou la prevention du diabete et des maladies associees au retrovirus
ITRM910696A0 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
FI971951A0 (fi) 2,2-dikloroalkaanikarboksyylihapot, menetelmät niiden valmistamiseksi, niitä sisältävät lääkkeet, ja niiden käyttö insuliiniresistanssin hoitoon
ZA975866B (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases.
NO20093253L (no) Forbindelser, farmasoytiske formuleringer og anvendelse av forbindelsene til fremstilling av legemiddel
IL72469A0 (en) Novel insulin derivatives,processes for their preparation and their use,and pharmaceutical agents for the treatment of diabetes mellitus
FR2848849B1 (fr) Poudre pour inhalation, capsule et trousse la contenant et son utilisation pour la preparation d'un medicament
ZA985392B (en) New derivatives of 2-(iminomethyl) amino-phenyl, their preparation their use as medicaments and the pharmaceutical compositions containing them
MY124146A (en) Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
TNSN98113A1 (fr) Procede de preparation de composes utiles pour le traitement de la resistance a l'insuline.
DE60220055D1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
HU9700060D0 (en) New compound, it's production and it's use as active component of a medicine
DZ2521A1 (fr) Compositions pharmaceutiques comprenant de la 5-Ä4-Ä2-(méthyl-n-(2-pyridyl)amino)éthoxyÜbenzylÜ-thiazolidine-2,4-dione et de l'insuline pour une méthode de traitement.
PL325865A1 (en) Selective antagonists of beta3-adrenergic receptor
DK28795A (da) Insulinholdigt polymerpræparat til oral administrering af insulin
FR2822069B1 (fr) Composition pharmaceutique comprenant un compose stimulant la secretion d'insuline et un derive de thiazolidinedione et son utilisation pour la preparation de medicamments destines a traiter le diabete
EP0272704A3 (fr) Emploi de dérivés de pyrazole pour le traitement de troubles de l'immunité et de la néphropathie
HUP0003634A3 (en) Use of thiazolidinedione and sulphonylurea derivatives for the preparation of pharmaceutical compositions treating diabetes
FR2714603B1 (fr) Composition dermatologique et son utilisation pour la préparation d'un médicament.
FR2778108B1 (fr) Dispositif d'administration transdermique de medicament par ionophorese
DK0785787T3 (da) Anvendelse af 1,5-benzodiazepinderivater til kontrol af mavetømning hos patienter med ikke insulinafhængig diabetes mellitus

Legal Events

Date Code Title Description
ST Notification of lapse